Cargando…
Outcomes and risk of subsequent breast events in breast‐conserving surgery patients with BRCA1 and BRCA2 mutation
PURPOSE: Previous studies provide inconsistent interpretations of the effect of inherited genetic factors on the survival and prognosis of patients with breast cancer. The aim of this study was to examine the effect of germline BRCA1 and BRCA2 mutation on survival and subsequent breast events in Chi...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050073/ https://www.ncbi.nlm.nih.gov/pubmed/31912664 http://dx.doi.org/10.1002/cam4.2836 |
_version_ | 1783502564322443264 |
---|---|
author | Ye, Fugui Huang, Liang Lang, Guantian Hu, Xin Di, Genhong Shao, Zhimin Cao, Ayong |
author_facet | Ye, Fugui Huang, Liang Lang, Guantian Hu, Xin Di, Genhong Shao, Zhimin Cao, Ayong |
author_sort | Ye, Fugui |
collection | PubMed |
description | PURPOSE: Previous studies provide inconsistent interpretations of the effect of inherited genetic factors on the survival and prognosis of patients with breast cancer. The aim of this study was to examine the effect of germline BRCA1 and BRCA2 mutation on survival and subsequent breast events in Chinese women who underwent breast‐conserving surgery. METHODS: A retrospective review of the clinical and pathological records was performed in patients diagnosed with primary invasive breast cancer between 2005 and 2018 in the cancer registry database. Clinicopathological data and data regarding treatment and outcomes, including date and site of disease progression, were collected. The survival outcomes and independent risk factors were conducted using SPSS. RESULTS: Overall, a total of 501 patients who underwent breast‐conserving surgery were identified and subjected to analyses, of which 63 cases with BRCA1 or BRCA2 mutation. The median age at diagnosis was 41 (range, 24‐74) for carriers and 37 (range, 17‐84) for noncarriers. After a median follow‐up time of 61 months (range, 8‐161) and 70 months (range, 0‐153), respectively, in carriers and noncarriers, the overall survival (P = .173) and disease‐free survival (P = .424) were not significantly different. Analogously, there was no significant difference between the two groups about the outcomes of ipsilateral breast tumor recurrence (P = .348), yet the contralateral breast cancer (CBC) was overt worse than noncarriers (P < .001). When adjusted to confounding factors, BRCA mutation was the only independent risk factors to CBC (HR = 7.89, P = .01). CONCLUSION: In this study, BRCA mutation carriers have higher risk of CBC. And, BRCA mutation is the only independent risk factor to CBC. Therefore, intensive surveillance and follow‐up as well as more effective individual prevention are urgent. Decisions on alternatively effective prevention, especially the prevention of CBC, are urgent and should take into account patient prognosis and preferences. |
format | Online Article Text |
id | pubmed-7050073 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70500732020-03-05 Outcomes and risk of subsequent breast events in breast‐conserving surgery patients with BRCA1 and BRCA2 mutation Ye, Fugui Huang, Liang Lang, Guantian Hu, Xin Di, Genhong Shao, Zhimin Cao, Ayong Cancer Med Cancer Prevention PURPOSE: Previous studies provide inconsistent interpretations of the effect of inherited genetic factors on the survival and prognosis of patients with breast cancer. The aim of this study was to examine the effect of germline BRCA1 and BRCA2 mutation on survival and subsequent breast events in Chinese women who underwent breast‐conserving surgery. METHODS: A retrospective review of the clinical and pathological records was performed in patients diagnosed with primary invasive breast cancer between 2005 and 2018 in the cancer registry database. Clinicopathological data and data regarding treatment and outcomes, including date and site of disease progression, were collected. The survival outcomes and independent risk factors were conducted using SPSS. RESULTS: Overall, a total of 501 patients who underwent breast‐conserving surgery were identified and subjected to analyses, of which 63 cases with BRCA1 or BRCA2 mutation. The median age at diagnosis was 41 (range, 24‐74) for carriers and 37 (range, 17‐84) for noncarriers. After a median follow‐up time of 61 months (range, 8‐161) and 70 months (range, 0‐153), respectively, in carriers and noncarriers, the overall survival (P = .173) and disease‐free survival (P = .424) were not significantly different. Analogously, there was no significant difference between the two groups about the outcomes of ipsilateral breast tumor recurrence (P = .348), yet the contralateral breast cancer (CBC) was overt worse than noncarriers (P < .001). When adjusted to confounding factors, BRCA mutation was the only independent risk factors to CBC (HR = 7.89, P = .01). CONCLUSION: In this study, BRCA mutation carriers have higher risk of CBC. And, BRCA mutation is the only independent risk factor to CBC. Therefore, intensive surveillance and follow‐up as well as more effective individual prevention are urgent. Decisions on alternatively effective prevention, especially the prevention of CBC, are urgent and should take into account patient prognosis and preferences. John Wiley and Sons Inc. 2020-01-07 /pmc/articles/PMC7050073/ /pubmed/31912664 http://dx.doi.org/10.1002/cam4.2836 Text en © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Cancer Prevention Ye, Fugui Huang, Liang Lang, Guantian Hu, Xin Di, Genhong Shao, Zhimin Cao, Ayong Outcomes and risk of subsequent breast events in breast‐conserving surgery patients with BRCA1 and BRCA2 mutation |
title | Outcomes and risk of subsequent breast events in breast‐conserving surgery patients with BRCA1 and BRCA2 mutation |
title_full | Outcomes and risk of subsequent breast events in breast‐conserving surgery patients with BRCA1 and BRCA2 mutation |
title_fullStr | Outcomes and risk of subsequent breast events in breast‐conserving surgery patients with BRCA1 and BRCA2 mutation |
title_full_unstemmed | Outcomes and risk of subsequent breast events in breast‐conserving surgery patients with BRCA1 and BRCA2 mutation |
title_short | Outcomes and risk of subsequent breast events in breast‐conserving surgery patients with BRCA1 and BRCA2 mutation |
title_sort | outcomes and risk of subsequent breast events in breast‐conserving surgery patients with brca1 and brca2 mutation |
topic | Cancer Prevention |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050073/ https://www.ncbi.nlm.nih.gov/pubmed/31912664 http://dx.doi.org/10.1002/cam4.2836 |
work_keys_str_mv | AT yefugui outcomesandriskofsubsequentbreasteventsinbreastconservingsurgerypatientswithbrca1andbrca2mutation AT huangliang outcomesandriskofsubsequentbreasteventsinbreastconservingsurgerypatientswithbrca1andbrca2mutation AT langguantian outcomesandriskofsubsequentbreasteventsinbreastconservingsurgerypatientswithbrca1andbrca2mutation AT huxin outcomesandriskofsubsequentbreasteventsinbreastconservingsurgerypatientswithbrca1andbrca2mutation AT digenhong outcomesandriskofsubsequentbreasteventsinbreastconservingsurgerypatientswithbrca1andbrca2mutation AT shaozhimin outcomesandriskofsubsequentbreasteventsinbreastconservingsurgerypatientswithbrca1andbrca2mutation AT caoayong outcomesandriskofsubsequentbreasteventsinbreastconservingsurgerypatientswithbrca1andbrca2mutation |